List of Figures
Figure 1: Cumulative Number of Tested Conditions and Associated Genes for Genetic Testing, 2012-2019
Figure 2: Impact Analysis on the Global Nucleic Acid Isolation and Purification Market
Figure 3: Nucleic Acid Isolation and Purification Market, (by Product), $Million, 2020 vs. 2031
Figure 4: Nucleic Acid Isolation and Purification Consumables Market, (by Type), $Million, 2020 vs. 2031
Figure 5: Nucleic Acid Isolation and Purification Consumables Market, (by Technology), $Million, 2020 vs. 2031
Figure 6: Nucleic Acid Isolation and Purification Consumables Market, (by End User), $Million, 2020 vs. 2031
Figure 7: Global Nucleic Acid Isolation and Purification Consumables Market Snapshot, (by Region) 2020 and 2031
Figure 8: Nucleic Acid Isolation and Purification Instrument Market, (by Technology), $Million, 2020 vs. 2031
Figure 9: Nucleic Acid Isolation and Purification Instrument Market, (by Throughput), $Million, 2020 vs. 2031
Figure 10: Global Nucleic Acid Isolation and Purification Instrument Market Snapshot, (by Region)
Figure 2.1: Global Nucleic Acid Isolation and Purification Market Segmentation
Figure 3.1: Global Nucleic Acid Isolation and Purification Market Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Forecast Methodology
Figure 4.1: North America Nucleic Acid Isolation and Purification Addressable Market, 2020-2031
Figure 4.2: EMEA Nucleic Acid Isolation and Purification Addressable Market, 2020-2031
Figure 4.3: Asia-Pacific Nucleic Acid Isolation and Purification Addressable Market, 2020-2031
Figure 4.4: Latin America Nucleic Acid Isolation and Purification Addressable Market, 2020-2031
Figure 4.5: Market Attractiveness Based on Key Characteristics
Figure 4.6: Impact of COVID-19 on the Global Nucleic Acid Isolation and Purification Market
Figure 4.5: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025)
Figure 4.6: Key Genetic Disorder Prevalence in the U.S., 2012-2017
Figure 5.1: Share of Key Developments and Strategies
Figure 6.1: Nucleic Acid Isolation and Purification Customer Preference (by Major Brand), N=27
Figure 6.2: Nucleic Acid Isolation and Purification Customer Satisfaction Level (5 Being the Highest) (by Brand) (N=27)
Figure 7.1: Nucleic Acid Isolation and Purification Market (by Product), $Million, 2020 and 2031
Figure 7.2: Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 7.3: Nucleic Acid Isolation and Purification Kits Market, $Million, 2020-2031
Figure 7.4: Nucleic Acid Isolation and Purification Reagents Market, $Million, 2020-2031
Figure 7.5: Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 8.1: Nucleic Acid Isolation and Purification Kits Market (by Workflow), $Million, 2020 and 2031
Figure 8.2: Sample Isolation/Extraction/Purification Kits Market, $Million, 2020-2031
Figure 8.3: DNA/RNA Clean-Up and concentration Kits Market, $Million, 2020-2031
Figure 8.4: DNA and RNA Quantification Kits Market, $Million, 2020-2031
Figure 8.5: Nucleic Acid Isolation and Purification Kits Market (by Analyte), $Million, 2020 and 2031
Figure 8.6: DNA Kits Market, $Million, 2020-2031
Figure 8.7: Market Share for DNA Kits Market, $Million, 2020
Figure 8.8: RNA Kits Market, $Million, 2020-2031
Figure 8.9: Market Share for RNA Kits Market, $Million, 2020
Figure 9.1: DNA Isolation and Purification Kits Market (by Source Type), $Million, 2020 and 2031
Figure 9.2: Cell-Free DNA Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.3: Market Share for Cell-Free DNA Isolation and Purification Kits Market, $Million, 2020
Figure 9.4: Cell-Free DNA Isolation and Purification Kits Market for Blood, $Million, 2020-2031
Figure 9.5: Cell-Free DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2020-2031
Figure 9.6: Cell-Free DNA Isolation and Purification Kits Market for Other Sources, $Million, 2020-2031
Figure 9.7: Cell-Free DNA Isolation and Purification Kits Market for Prenatal and Hereditary Testing, $Million, 2020-2031
Figure 9.8: Cell-Free DNA Isolation and Purification Kits Market for Tumor Testing, $Million, 2020-2031
Figure 9.9: Cell-Free DNA Isolation and Purification Kits Market for Transplantation, $Million, 2020-2031
Figure 9.10: Genomic DNA Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.11: Market Share for Genomic DNA Isolation and Purification Kits Market, $Million, 2020
Figure 9.12: Genomic DNA Isolation and Purification Kits Market for Blood, $Million, 2020-2031
Figure 9.13: Market Share for Genomic DNA Isolation and Purification Market for Blood, $Million, 2020
Figure 9.14: Genomic DNA Isolation and Purification Kits Market for Body Fluids, $Million, 2020-2031
Figure 9.15: Market Share for Genomic DNA Isolation and Purification Kits Market for Body Fluids, $Million, (2020)
Figure 9.16: Genomic DNA Isolation and Purification Kits Market for Buccal, $Million, 2020-2031
Figure 9.17: Market Share for Genomic DNA Isolation and Purification Kits Market for Buccal, $Million, 2020
Figure 9.18: Genomic DNA Isolation and Purification Kits Market for Cell/Cultured Cell, $Million, 2020-2031
Figure 9.19: Market Share for Genomic DNA Isolation and Purification Kits Market for Cell/Cultured Cell, $Million, 2020
Figure 9.20: Genomic DNA Isolation and Purification Kits Market for FFPE, $Million, 2020-2031
Figure 9.21: Market Share for Genomic DNA Isolation and Purification Kits Market for FFPE, $Million, 2020
Figure 9.22: Genomic DNA Isolation and Purification Kits Market for Forensic, $Million, 2020-2031
Figure 9.23: Market Share for Genomic DNA Isolation and Purification Kits Market for Forensic, $Million, 2020
Figure 9.24: Genomic DNA Isolation and Purification Kits Market for Plant, $Million, 2020-2031
Figure 9.25: Market Share for Genomic DNA Isolation and Purification Kits Market for Plant, $Million, 2020
Figure 9.26: Genomic DNA Isolation and Purification Kits Market for Saliva/Swab, $Million, 2020-2031
Figure 9.27: Market Share for Genomic DNA Isolation and Purification Kits Market for Saliva/Swab, $Million, 2020
Figure 9.28: Genomic DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2020-2031
Figure 9.29: Market Share for Genomic DNA Isolation and Purification Kits Market for Serum/Plasma, $Million, 2020
Figure 9.30: Genomic DNA Isolation and Purification Kits Market for Tissue, $Million, 2020-2031
Figure 9.31: Market Share for Genomic DNA Isolation and Purification Kits Market for Tissue, $Million, 2020
Figure 9.32: Genomic DNA Isolation and Purification Kits Market for Combined Segment, $Million, 2020-2031
Figure 9.33: Market Share for Genomic DNA Isolation and Purification Kits Market for Stool, Urine, and Other Samples, $Million, 2020
Figure 9.34: Microbe DNA Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.35: Market Share for Microbe DNA Isolation and Purification Kits Market, $Million, 2020
Figure 9.36: Microbial DNA Isolation and Purification Kits Market for Bacterial, $Million, 2020-2031
Figure 9.37: Market Share for Microbial DNA Isolation and Purification Kits Market for Bacterial, $Million, 2020
Figure 9.38: Microbial DNA Isolation and Purification Kits Market for Fungus, $Million, 2020-2031
Figure 9.39: Market Share for Microbial DNA Isolation and Purification Kits Market for Fungus, $Million, 2020
Figure 9.40: Microbial DNA Isolation and Purification Kits Market for Yeast, $Million, 2020-2031
Figure 9.41: Market Share for Microbial DNA Isolation and Purification Kits Market for Yeast, $Million, 2020
Figure 9.42: Microbial DNA Isolation and Purification Kits Market for Other Sources, $Million, 2020-2031
Figure 9.43: Plasmid DNA Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.44: Market Share for Plasmid DNA Isolation and Purification Kits Market, $Million, 2020
Figure 9.45: Plasmid GigaPrep Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.46: Market Share for Plasmid GigaPrep Isolation and Purification Kits Market, $Million, 2020
Figure 9.47: Plasmid MaxiPrep Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.48: Market Share for Plasmid MaxiPrep Isolation and Purification Kits Market, $Million, 2020
Figure 9.49: Plasmid MegaPrep Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.50: Market Share for Plasmid MegaPrep Isolation and Purification Kits Market, $Million, 2020
Figure 9.51: Plasmid MidiPrep Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.52: Market Share for Plasmid MidiPrep Isolation and Purification Kits Market, $Million, 2020
Figure 9.53: Plasmid MiniPrep Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.54: Market Share for Plasmid MiniPrep Isolation and Purification Kits Market, $Million, 2020
Figure 9.55: Viral DNA Isolation and Purification Kits Market, $Million, 2020-2031
Figure 9.56: Market Share for Viral DNA Isolation and Purification Kits Market, $Million, 2020
Figure 10.1: RNA Isolation and Purification Kits Market, $Million, 2020 and 2031
Figure 10.2: Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.3: Genomic RNA Kits Market Share, 2020
Figure 10.4: Genomic RNA Kits for Blood Market, $Million, 2020-2031
Figure 10.5: Genomic RNA Extraction Kits from Blood, Market Share, 2020
Figure 10.6: Body Fluids Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.7: Cell/Cultured Cell Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.8: Cell/Cultured Cell Genomic RNA Extraction Kits, Market Share, 2020
Figure 10.9: FFPE Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.10: FFPE Genomic RNA Extraction Kits, Market Share, 2020
Figure 10.11: Plant Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.12: Plant Genomic RNA Extraction Kits, Market Share, 2020
Figure 10.13: Saliva/Swab Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.14: Serum/Plasma Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.15: Serum/Plasma Genomic RNA Extraction Kits, Market Share, 2020
Figure 10.16: Tissue Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.17: Tissue Genomic RNA Extraction Kits, Market Share, 2020
Figure 10.18: Urine Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.19: Other Genomic RNA Kits Market, $Million, 2020-2031
Figure 10.20: Microbial RNA Kits Market, $Million, 2020-2031
Figure 10.21: Microbial RNA Kits Market Share, 2020
Figure 10.22: Bacterial RNA Kits Market, $Million, 2020-2031
Figure 10.23: Bacterial RNA Kits Market Share, 2020
Figure 10.24: Yeast RNA Kits Market, $Million, 2020-2031
Figure 10.25: Yeast RNA Kits Market Share, 2020
Figure 10.26: Fungus RNA Kits Market, $Million, 2020-2031
Figure 10.27: Fungal RNA Kits Market Share, 2020
Figure 10.28: Other Microbial RNA Kits Market, $Million, 2020-2031
Figure 10.29: Viral RNA Kits Market, $Million, 2020-2031
Figure 10.30: Viral RNA Kits Market Share, 2020
Figure 10.31: Cell-Free RNA Kits Market, $Million, 2020-2031
Figure 10.32: cell-free RNA Kits Market Share, 2020
Figure 10.33: Serum/Plasma Cell-Free RNA Kits Market, $Million, 2020-2031
Figure 10.34: Other Cell-Free RNA Kits Market, $Million, 2020-2031
Figure 11.1: Nucleic Acid Isolation and Purification Consumables Market (by Technology), $Million, 2020 and 2031
Figure 11.2: Silica-Based Consumables Market, $Million, 2020-2031
Figure 11.3: Magnetic Particle-based Consumables Market, $Million, 2020-2031
Figure 12.1: Nucleic Acid Isolation and Purification Consumables Market (by Technological Downstream Applications), $Million, 2020 and 2031
Figure 12.2: PCR Market, $Million, 2020-2031
Figure 12.3: qPCR Market, $Million, 2020-2031
Figure 12.4: NGS Market, $Million, 2020-2031
Figure 12.5: Cloning Market, $Million, 2020-2031
Figure 12.6: Microarray Market, $Million, 2020-2031
Figure 12.7: Blotting Techniques Market, $Million, 2020-2031
Figure 12.8: Other Applications Market, $Million, 2020-2031
Figure 13.1: Nucleic Acid Isolation and Purification Consumables Market (by End User), $Million, 2020 and 2031
Figure 13.2: Academic Research Institutes and Laboratories Market, $Million, 2020-2031
Figure 13.3: Pharmaceutical and Biotechnology Companies Market, $Million, 2020-2031
Figure 13.4: Contract Research Organizations Market, $Million, 2020-2031
Figure 13.5: Applied Testing Market, $Million, 2020-2031
Figure 13.6: Clinical Diagnostic Center Market, $Million, 2020-2031
Figure 14.1: Nucleic Acid Isolation and Purification Consumables Market (by Region), $Million, 2020 and 2031
Figure 14.2: North America Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.3: U.S. Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.4: Canada Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.5: EMEA Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.6: LATAM Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.7: APAC Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.8: China Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.9: Japan Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 14.10: Rest-of-APAC Nucleic Acid Isolation and Purification Consumables Market, $Million, 2020-2031
Figure 15.1: Nucleic Acid Isolation and Purification Instrument Market (by Workflow), $Million, 2020 and 2031
Figure 15.2: Isolation/Extraction/Purification Instrument Market, $Million, 2020-2031
Figure 15.3: Quality Control/Quantification Instrument Market, $Million, 2020-2031
Figure 15.4: Nucleic Acid Extraction/Isolation/Purification Instrument Market (by Technology), $Million, 2020 and 2031
Figure 15.5: Automated Spin Column-Based Instrument Market, $Million, 2020-2031
Figure 15.6: Magnetic Bead-based Instrument Market, $Million, 2020-2031
Figure 15.7: Automated Liquid Handling Instruments Market, $Million, 2020-2031
Figure 15.8: Nucleic Acid Extraction/Isolation/Purification Instrument Market (by Throughput), $Million, 2020 and 2031
Figure 15.9: Low Throughput Instrument Market, $Million, 2020-2031
Figure 15.10: Medium Throughput Instrument Market, $Million, 2020-2031
Figure 15.11: High Throughput Instrument Market, $Million, 2020-2031
Figure 15.12: Quality Control/Quantification Instruments, (by Technology), $Million, 2020 and 2031
Figure 15.13: Spectrophotometers Market, $Million, 2020-2031
Figure 15.14: Fluorometers Market, $Million, 2020-2031
Figure 15.15: Others Market, $Million, 2020-2031
Figure 15.16: Nucleic Acid Isolation and Purification Instrument Market (by End User), $Million, 2020 and 2031
Figure 15.17: Nucleic Acid Isolation and Purification Instrument Market for Academic Research Institutes, $Million, 2020-2031
Figure 15.18: Nucleic Acid Isolation and Purification Instrument Market for Pharmaceutical and Biotechnology Companies, $Million, 2020-2031
Figure 15.19: Nucleic Acid Isolation and Purification Instrument Market for Clinical Diagnostic Centers, $Million, 2020-2031
Figure 15.20: Nucleic Acid Isolation and Purification Instrument Market for Applied Testing, $Million, 2020-2031
Figure 15.21: Nucleic Acid Isolation and Purification Instrument Market for Contract Research Organizations, $Million, 2020-2031
Figure 15.22: Nucleic Acid Isolation and Purification Instrument Market (by Region), $Million, 2020 and 2031
Figure 15.23: North America Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.24: North America Nucleic Acid Isolation and Purification Instrument Market (by Country), $Million, 2020-2031
Figure 15.25: U.S. Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.26: Canada Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.27: EMEA Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.28: APAC Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.29: APAC Nucleic Acid Isolation and Purification Instrument Market (by Country) $Million, 2020-2031
Figure 15.30: China Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.31: Japan Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.32: Rest-of-APAC Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 15.33: LATAM Nucleic Acid Isolation and Purification Instrument Market, $Million, 2020-2031
Figure 16.1: Market Share Analysis for the Global Nucleic Acid Isolation and Purification (Instrument and Kits) Market, 2020
Figure 16.2: Market Share Analysis for the Global Nucleic Acid Isolation and Purification Instrument Market, 2020
Figure 16.3: Global Nucleic Acid Isolation and Purification Kits Market Share, 2020
Figure 16.4: Market Share Analysis for the North America Nucleic Acid Isolation and Purification (Instrument and Kits) Market, 2020
Figure 16.5: Market Share Analysis for the North America Nucleic Acid Isolation and Purification Instrument Market, 2018
Figure 16.6: Market Share Analysis for the North America Nucleic Acid Isolation and Purification Kits Market, 2020
Figure 16.7: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification (Instrument and Kits) Market, 2020
Figure 16.8: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification Instrument Market, 2020
Figure 16.9: Market Share Analysis for the EMEA Nucleic Acid Isolation and Purification Kits Market, 2020
Figure 16.10: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by End User)
Figure 16.11: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by Region)
Figure 16.12: Growth Share Matrix for Global Nucleic Acid Isolation and Purification Market (by Product)
Figure 17.1: Business Expansion Opportunity Mapping (by Product)
Figure 17.2: Business Expansion Opportunity Mapping (by Region)
Figure 17.3: Nucleic Acid Isolation and Purification Market: SWOT Analysis
Figure 18.1: Total Number of Companies Profiles
Figure 18.2: Agilent Technologies, Inc.: Key Product Portfolio
Figure 18.3: Agilent Technologies, Inc.: Overall Financials, 2018-2020
Figure 18.4: Agilent Technologies, Inc.: Revenue (by Segment), 2018-2020
Figure 18.5: Agilent Technologies, Inc.: Revenue (by Region), 2018-2020
Figure 18.6: Agilent Technologies, Inc.: R&D Expenditure, 2018-2020
Figure 18.7: Agilent Technologies, Inc.: SWOT Analysis
Figure 18.8: Analytik Jena AG: Key Product Portfolio
Figure 18.9: Analytik Jena AG: SWOT Analysis
Figure 18.10: AutoGen, Inc.: Key Product Portfolio
Figure 18.11: AutoGen, Inc.: SWOT Analysis
Figure 18.12: Bio-Rad Laboratories, Inc.: Key Product Portfolio
Figure 18.13: Bio-Rad Laboratories, Inc.: Overall Financials, 2018-2020
Figure 18.14: Bio-Rad Laboratories, Inc.: Sales (by Segment), $Million, 2018-2020
Figure 18.15: Bio-Rad Laboratories, Inc.: Sales (by Region), 2018-2020
Figure 18.16: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2018-2020
Figure 18.17: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 18.18: F. Hoffmann-La Roche AG: Key Product Portfolio
Figure 18.19: F. Hoffmann-La Roche AG: Overall Financials, 2018-2020
Figure 18.20: F. Hoffmann-La Roche AG: Revenue (by Segment), $Million, 2018-2020
Figure 18.21: F. Hoffmann-La Roche AG: Revenue (by Region), 2018-2020
Figure 18.22: F. Hoffmann-La Roche AG: R&D Expenditure, 2018-2020
Figure 18.23: F. Hoffmann-La Roche AG: SWOT Analysis
Figure 18.24: Illumina, Inc.: Key Product Portfolio
Figure 18.25: Illumina, Inc.: Overall Financials, 2018-2020
Figure 18.26: Illumina, Inc.: Revenue (by Segment), $Million, 2018-2020
Figure 18.27: Illumina, Inc.: Revenue (by Region), 2018-2020
Figure 18.28: Illumina, Inc.: R&D Expenditure, 2018-2020
Figure 18.29: Illumina, Inc.: SWOT Analysis
Figure 18.30: Merck KGaA: Key Product Offerings
Figure 18.31: Merck KGaA: Overall Financials, 2018-2020
Figure 18.32: Merck KGaA: Revenue (by Segment), $Million, 2018-2020
Figure 18.33: Merck KGaA: Revenue (by Region), 2018-2020
Figure 18.34: Merck KGaA: R&D Expenditure, 2018-2020
Figure 18.35: Merck KGaA: SWOT Analysis
Figure 18.36: Meridian Bioscience: Key Product Portfolio
Figure 18.37: Meridian Bioscience: Overall Financials, 2018-2020
Figure 18.38: Meridian Bioscience Revenue (by Segment), 2018-2020
Figure 18.39: Meridian Bioscience: Revenue (by Region), 2018-2020
Figure 18.40: Meridian Bioscience: R&D Expenditure, 2018-2020
Figure 18.41: Meridian Bioscience: SWOT Analysis
Figure 18.42: Macherey-Nagel GmbH & Co KG: Key Product Portfolio
Figure 18.43: Macherey-Nagel GmbH & Co KG: SWOT Analysis
Figure 18.44: New England Biolabs, Inc: Key Product Offerings
Figure 18.45: New England Biolabs, Inc.: SWOT Analysis
Figure 18.46: Norgen Biotek Corp.: Key Product Portfolio
Figure 18.47: Norgen Biotek Corp.: SWOT Analysis
Figure 18.48: Omega Bio-tek, Inc.: Key Product Portfolio
Figure 18.49: Omega Bio-Tek: SWOT Analysis
Figure 18.50: Orasure Technologies, Inc.: Key Product Portfolio
Figure 18.51: Orasure Technologies, Inc.: Overall Financials, 2018-2020
Figure 18.52: Orasure Technologies, Inc. Revenue (by Segment), 2018-2020
Figure 18.53: Orasure Technologies, Inc.: Revenue (by Region), 2018-2020
Figure 18.54: Orasure Technologies, Inc.: R&D Expenditure, 2018-2020
Figure 18.55: Orasure Technologies, Inc.: SWOT Analysis
Figure 18.56: PerkinElmer, Inc.: Key Product Portfolio
Figure 18.57: Perkin Elmer, Inc.: Overall Financials, (2018-2020)
Figure 18.58: Perkin Elmer, Inc.: Revenue (by Business Segment), 2018-2020
Figure 18.59: Perkin Elmer, Inc.: Revenue (by Region), 2018-2020
Figure 18.60: PerkinElmer, Inc.: R&D Expenditure, 2018-2020
Figure 18.61: PerkinElmer, Inc.: SWOT Analysis
Figure 18.62: Promega Corporation: Key Product Portfolio
Figure 18.63: Promega Corporation: SWOT Analysis
Figure 18.64: QIAGEN N.V.: Key Product Offerings
Figure 18.65: QIAGEN N.V.: Overall Financials, 2018-2020
Figure 18.66: QIAGEN N.V.: Revenue (by Segment), 2018-2020
Figure 18.67: QIAGEN N.V.: Revenue (by Region), 2016-2018
Figure 18.68: QIAGEN N.V.: R&D Expenditure, 2018-2020
Figure 18.69: QIAGEN N.V.: SWOT Analysis
Figure 18.70: Sage Science, Inc.: Key Product Portfolio
Figure 18.71: Sage Science, Inc.: SWOT Analysis
Figure 18.72: Tecan Group: Key Product Portfolio
Figure 18.73: Tecan Group: Overall Financials, 2018-2020
Figure 18.74: Tecan Group Revenue (by Segment), 2018-2020
Figure 18.75: Tecan Group: Revenue (by Region), 2018-2020
Figure 18.76: Tecan Group: R&D Expenditure, 2018-2020
Figure 18.77: Tecan Group: SWOT Analysis
Figure 18.78: Thermo Fisher Scientific Inc.: Key Product Offerings
Figure 18.79: Thermo Fisher Scientific Inc.: Overall Financials, 2018-2020
Figure 18.80: Thermo Fisher Scientific Inc: Sales (by Segment), $Million, 2018-2020
Figure 18.81: Thermo Fisher Scientific Inc.: Sales (by Region), 2018-2020
Figure 18.82: Thermo Fisher Scientific Inc.: R&D Expenditure, 2018-2020
Figure 18.83: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 18.84: Zymo Research: Key Product Portfolio
Figure 18.85: Zymo Research: SWOT Analysis